Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H19N.CH4O3S |
| Molecular Weight | 345.456 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CNCC12CCC(C3=CC=CC=C13)C4=CC=CC=C24
InChI
InChIKey=ULOQELONFAGTLP-UHFFFAOYSA-N
InChI=1S/C18H19N.CH4O3S/c1-19-12-18-11-10-13(14-6-2-4-8-16(14)18)15-7-3-5-9-17(15)18;1-5(2,3)4/h2-9,13,19H,10-12H2,1H3;1H3,(H,2,3,4)
Benzoctamine (Tacitin), a psychotropic drug, known to exert in man an anti-anxiety effect. Its action also was studied when given as a hypnotic or sedative in patients with respiratory failure. Benzoctamine decreases 5-HT turnover in the brain and this action may play a role in the anti-anxiety effect of the drug.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P31645 Gene ID: 6532.0 Gene Symbol: SLC6A4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/4480288 |
|||
Target ID: CHEMBL2095200 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6738305 |
7.0 null [pIC50] |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20791872
10 mg of benzoctamine and 20 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID90995916
Created by
admin on Wed Apr 02 10:14:00 GMT 2025 , Edited by admin on Wed Apr 02 10:14:00 GMT 2025
|
PRIMARY | |||
|
74083969
Created by
admin on Wed Apr 02 10:14:00 GMT 2025 , Edited by admin on Wed Apr 02 10:14:00 GMT 2025
|
PRIMARY | |||
|
74401-28-8
Created by
admin on Wed Apr 02 10:14:00 GMT 2025 , Edited by admin on Wed Apr 02 10:14:00 GMT 2025
|
PRIMARY | |||
|
IYQ3K620CD
Created by
admin on Wed Apr 02 10:14:00 GMT 2025 , Edited by admin on Wed Apr 02 10:14:00 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD